{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:02:37Z","timestamp":1784998957801,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K19095"],"award-info":[{"award-number":["JP25K19095"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiotherapy (RT) utilization in the last 30 days before death has been reported at 5\u201310%, but data from Japan are lacking. This study aimed to characterize patterns of end-of-life RT utilization among patients with malignant neoplasms in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the DeSC insurance claims database, patients who died between May 2016 and December 2024 with a primary malignant neoplasm diagnosis were identified. RT utilization in the last 30 days before death, treatment techniques, and the proportions of potentially excessive RT (IMRT, stereotactic irradiation, particle beam therapy, or \u2265\u200911 treatment days) and single-fraction RT were examined. Multivariable logistic regression was used to explore factors associated with RT utilization and single-fraction RT use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 329,230 deceased patients, 8799 (2.7%) received RT in the last 30 days before death. Potentially excessive RT was observed in 33.7%, declining from 43.1% in 2016 to 27.2% in 2024. Single-fraction RT accounted for 5.5%, increasing from 2.8% in 2016 to 8.8% in 2024. On multivariable analysis, older age, higher comorbidity, and palliative care unit admission were associated with non-use of RT, while bone metastasis, higher-function hospitals, and urban location were associated with higher utilization. Bone metastasis, palliative care unit admission, and higher hospital function were associated with greater single-fraction RT use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The end-of-life RT utilization rate in Japan was 2.7%, lower than rates reported in other countries. Potentially excessive RT showed a declining trend, while single-fraction RT showed an increasing trend. These findings provide baseline data for optimizing end-of-life RT practices in Japan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10147-026-03076-1","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:30:32Z","timestamp":1779985832000},"page":"1636-1644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy utilization in the last 30 days before death among patients with malignant neoplasms in Japan: a claims database study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7354-4063","authenticated-orcid":false,"given":"Kazuya","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Jingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"3076_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.radonc.2017.09.016","volume":"125","author":"KR Park","year":"2017","unstructured":"Park KR, Lee CG, Tseng YD et al (2017) Palliative radiation therapy in the last 30 days of life: a systematic review. Radiother Oncol 125:193\u2013199. https:\/\/doi.org\/10.1016\/j.radonc.2017.09.016","journal-title":"Radiother Oncol"},{"key":"3076_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1200\/JCO.2012.45.0585","volume":"31","author":"BA Guadagnolo","year":"2013","unstructured":"Guadagnolo BA, Liao KP, Elting L et al (2013) Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31:80\u201387. https:\/\/doi.org\/10.1200\/JCO.2012.45.0585","journal-title":"J Clin Oncol"},{"key":"3076_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000367629","volume":"88","author":"KW Matter-Walstra","year":"2015","unstructured":"Matter-Walstra KW, Achermann R, Rapold R et al (2015) Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89\/09. Oncology 88:18\u201327. https:\/\/doi.org\/10.1159\/000367629","journal-title":"Oncology"},{"key":"3076_CR4","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00520-015-2676-y","volume":"23","author":"P Grendarova","year":"2015","unstructured":"Grendarova P, Sinnarajah A, Trotter T et al (2015) Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010. Support Care Cancer 23:3059\u20133067. https:\/\/doi.org\/10.1007\/s00520-015-2676-y","journal-title":"Support Care Cancer"},{"key":"3076_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1472-684X-13-49","volume":"13","author":"J Huang","year":"2014","unstructured":"Huang J, Wai ES, Lau F et al (2014) Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliat Care 13:49. https:\/\/doi.org\/10.1186\/1472-684X-13-49","journal-title":"BMC Palliat Care"},{"key":"3076_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/0284186X.2014.948061","volume":"54","author":"M Anshushaug","year":"2015","unstructured":"Anshushaug M, Gynnild MA, Kaasa S et al (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol 54:395\u2013402. https:\/\/doi.org\/10.3109\/0284186X.2014.948061","journal-title":"Acta Oncol"},{"key":"3076_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1748-717X-7-167","volume":"7","author":"C Gillan","year":"2012","unstructured":"Gillan C, Briggs K, Goytisolo Pazos A et al (2012) Barriers to accessing radiation therapy in Canada: a systematic review. Radiat Oncol 7:167. https:\/\/doi.org\/10.1186\/1748-717X-7-167","journal-title":"Radiat Oncol"},{"key":"3076_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","volume":"116","author":"JM Borras","year":"2015","unstructured":"Borras JM, Lievens Y, Dunscombe P et al (2015) The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 116:38\u201344. https:\/\/doi.org\/10.1016\/j.radonc.2015.04.018","journal-title":"Radiother Oncol"},{"key":"3076_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/jrr\/rrab129","volume":"63","author":"H Numasaki","year":"2022","unstructured":"Numasaki H, Nakada Y, Okuda Y et al (2022) Japanese structure survey of radiation oncology in 2015. J Radiat Res 63:230\u2013246. https:\/\/doi.org\/10.1093\/jrr\/rrab129","journal-title":"J Radiat Res"},{"key":"3076_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"3076_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676\u2013682. https:\/\/doi.org\/10.1093\/aje\/kwq433","journal-title":"Am J Epidemiol"},{"key":"3076_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","volume":"17","author":"CN Klabunde","year":"2007","unstructured":"Klabunde CN, Legler JM, Warren JL et al (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17:584\u2013590. https:\/\/doi.org\/10.1016\/j.annepidem.2007.03.011","journal-title":"Ann Epidemiol"},{"key":"3076_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2188\/jea.JE20170241","volume":"29","author":"T Morishima","year":"2019","unstructured":"Morishima T, Matsumoto Y, Koeda N et al (2019) Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients. J Epidemiol 29:110\u2013115. https:\/\/doi.org\/10.2188\/jea.JE20170241","journal-title":"J Epidemiol"},{"key":"3076_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/s0360-3016(02)04147-0","volume":"55","author":"JSY Wu","year":"2003","unstructured":"Wu JSY, Wong R, Johnston M et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594\u2013605. https:\/\/doi.org\/10.1016\/s0360-3016(02)04147-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3076_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jjco\/hyy117","volume":"48","author":"Y Sato","year":"2018","unstructured":"Sato Y, Miyashita M, Sato K et al (2018) End-of-life care for cancer patients in Japanese acute care hospitals: a nationwide retrospective administrative database survey. Jpn J Clin Oncol 48:877\u2013883. https:\/\/doi.org\/10.1093\/jjco\/hyy117","journal-title":"Jpn J Clin Oncol"},{"key":"3076_CR16","doi-asserted-by":"publisher","first-page":"e66116","DOI":"10.1371\/journal.pone.0066116","volume":"8","author":"N Ooba","year":"2013","unstructured":"Ooba N, Setoguchi S, Ando T et al (2013) Claims-based definition of death in Japanese claims database: validity and implications. PLoS ONE 8:e66116. https:\/\/doi.org\/10.1371\/journal.pone.0066116","journal-title":"PLoS ONE"},{"key":"3076_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12199-019-0819-3","volume":"24","author":"M Sakai","year":"2019","unstructured":"Sakai M, Ohtera S, Iwao T et al (2019) Validation of claims data to identify death among aged persons utilizing enrollment data from health insurance unions. Environ Health Prev Med 24:63. https:\/\/doi.org\/10.1186\/s12199-019-0819-3","journal-title":"Environ Health Prev Med"},{"key":"3076_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/jjco\/hyy031","volume":"48","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, Konishi K, Komatsu T et al (2018) Patterns of radiotherapy infrastructure in Japan and in other countries with well-developed radiotherapy infrastructures. Jpn J Clin Oncol 48:476\u2013479. https:\/\/doi.org\/10.1093\/jjco\/hyy031","journal-title":"Jpn J Clin Oncol"},{"key":"3076_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jrr\/rrag004","volume":"67","author":"Y Koike","year":"2026","unstructured":"Koike Y, Nakamura S, Numasaki H et al (2026) Geographic access to radiotherapy facilities in Japan. J Radiat Res 67:259\u2013265. https:\/\/doi.org\/10.1093\/jrr\/rrag004","journal-title":"J Radiat Res"},{"key":"3076_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0885-3924(98)00145-6","volume":"17","author":"M Pirovano","year":"1999","unstructured":"Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manag 17:231\u2013239. https:\/\/doi.org\/10.1016\/s0885-3924(98)00145-6","journal-title":"J Pain Symptom Manag"},{"key":"3076_CR21","doi-asserted-by":"publisher","first-page":"e2420472","DOI":"10.1001\/jamanetworkopen.2024.20472","volume":"7","author":"KE Bischoff","year":"2024","unstructured":"Bischoff KE, Patel K, Boscardin WJ et al (2024) Prognoses associated with Palliative Performance Scale scores in modern palliative care practice. JAMA Netw Open 7:e2420472. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.20472","journal-title":"JAMA Netw Open"},{"key":"3076_CR22","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/j.jpainsymman.2025.12.027","volume":"71","author":"A Poelzer","year":"2026","unstructured":"Poelzer A, Baracos VE, Sellick M et al (2026) Evaluation of the Palliative Prognostic Score (PaP) in a cancer center-based palliative care clinic. J Pain Symptom Manag 71:e464\u2013e470. https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.12.027","journal-title":"J Pain Symptom Manag"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03076-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:35:49Z","timestamp":1784997349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03076-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3076"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03076-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SO received travel fee from Boston Scientific Japan, and KJ received a scholarship donation from Elekta KK. Regarding the other authors, they have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This observational study used an anonymized database, and informed consent was waived.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Tohoku University Graduate School of Medicine (approval number: 2025-1-452).","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}